1. Introduction {#sec1}
===============

Large bone defects caused by various bone diseases such as severe trauma, tumor resection or bone infection have long been grand challenges worldwide due to their weak capacity to self-regenerate \[[@bib1]\]. Clinically, autografts originated from fibula, ilium and rib are perceived as gold standard for small bone defects owing to their outstanding osteoconductivity and osteoinductivity. However, the donor shortage and donor site mobility severely restrict the therapeutic use of autografts for large bone defects \[[@bib2]\]. Allografts are commonly regarded as a suboptimal option compared to autografts, while they have risks in raising uncontrollable immune response and transmitting disease \[[@bib3]\]. Therefore, there is a strong clinical demand in the development of advanced synthetic bone substitutes with high therapeutic efficacy as alternatives to autologous and allogous grafts.

Bone tissue engineering (BTE) is a promising approach for large bone defect treatment \[[@bib4]\]. In BTE, a critical challenge is to develop a proper three dimensional (3D) porous scaffold which can be acellular or cells/drugs-loaded as a temporary matrix for bone in-growth and regeneration \[[@bib5]\]. An ideal scaffold should be capable of supporting or promoting cell adhesion, proliferation and differentiation as well as vascularization and osteointegration \[[@bib6]\]. Currently used biomaterials for BTE scaffolds can be roughly divided into three types including bioactive ceramics, degradable polymers and composites \[[@bib7]\]. Bio-ceramics such as hydroxyapatite (HA), tri-calcium phosphate (TCP) and bioactive glasses (BG) have favorable biocompatibility and osteoconductivity, whereas they are rarely used alone as scaffold materials due to their brittleness and difficulty for processing \[[@bib8], [@bib9], [@bib10]\]. Synthetic polymers such as poly-lactic acid (PLA), poly-glycolic acid (PGA) and their copolymers (PLGA) have been extensively used in BTE field due to their controllable degradation rates and easiness in scaffold forming \[[@bib11],[@bib12]\]. However, these synthetic polymers have drawbacks such as poor bioactivity and low ability to interact with cells. Thus, composite scaffolds with polymers as matrices and bioactive ceramics as functional fillers have been widely developed in order to take advantages of the favorable osteoconductivity of bio-ceramics and adjustable degradability of polymers \[[@bib13], [@bib14], [@bib15]\]. Unfortunately, current polymer/bio-ceramic composite scaffolds are still found to be insufficiently osteoinductive. Hence, growth factors such as bone morphogenetic proteins (BMPs) and vascular endothelial growth factors (VEGFs) have been reported to be further loaded into the scaffold systems for enhanced bone regeneration \[[@bib16], [@bib17], [@bib18]\]. However, the high cost and short half-life are considered as two major limitations for the extensive applications of these growth factors clinically.

Similar to bone, nacre and pearl are natural composite materials consisting of highly ordered calcium carbonate crystals (\~95 wt%) cemented by an organic matrix (\~5 wt%), exhibiting a typical 'brick and mortar' microstructure \[[@bib19]\]. There are *in vitro* and *in vivo* evidences showing the osteogenic potential of nacre. Lopez et al. found that nacre could lead to the formation of bone-like nodules induced by human osteoblasts \[[@bib20]\]. Green et al. reported that human bone marrow-derived stromal cells (hBMSCs) co-cultured with nacre chips expressed higher alkaline phosphatase (ALP) activity compared to the control group treated by BMP-2, indicating the osteoinductive potential of nacre \[[@bib21]\]. In an *in vivo* case, nacre powders mixed with autologous blood were injected between the fifth and sixth lumbar vertebrae of rabbits. The results showed that nacre could induce endocontrodral bone formation like autografts and the spinal fusion was achieved by 5 weeks \[[@bib22]\]. In another case, blood-mixed nacre powders were injected into the bone missing area of human upper jaw. After 6 months, osteoblast activation and new bone formation were observed throughout the implant material \[[@bib23]\]. Although the exact mechanism by which nacre promotes bone regeneration still remains veiled, scientists have speculated that the organic component of nacre may contain water soluble signal molecules that can stimulate osteogenesis. Bedouet et al. reported that small molecules (\<1 kDa), especially peptides, were prevalent in nacre \[[@bib24]\]. Lamghari et al. found that the stimulatory effect of nacre water soluble matrix (WSM) on BMSCs was similar to that of tumor growth factor-β (TGF-β) and BMPs \[[@bib25]\]. Rousseau et al. suggested that WSM of nacre had higher efficacy in accelerating osteoblastic differentiation than dexamethasone \[[@bib26]\]. In general, nacre is considered to be promising for BTE applications due to its favorable osteogenic capacity. Moreover, the osteogenic signal molecules reside in nacre could be potential alternatives for those expensive growth factors.

As nacre and pearl are non-porous as well as difficult to mold and degrade, their powders are commonly used as functional fillers in 3D porous composite scaffolds. In recent years, several kinds of nacre- or pearl-containing composite scaffolds have been developed through different techniques \[[@bib27]\]. Xu et al. employed low-temperature deposition manufacturing to fabricate PLGA/pearl composite scaffold. The pearl/PLGA scaffold promoted the ALP activity, collagen I (Col-I) synthesis in marrow stem cells (MSCs) *in vitro* compared to PLGA/TCP scaffold \[[@bib28]\]. Yang et al. reported that PLGA/pearl composite scaffold fabricated by gel casting and salt leaching method could promote the growth of osteoblasts *in vitro* compared to PLGA control \[[@bib29]\]. Zhang et al. developed poly-caprolactone (PCL)/pearl scaffold using 3D printing technique. The proliferation, ALP activity and bone related gene expressions such as osteocalcin (OCN), bone sialoprotein (BSP), BMP-2 and Col-I were significantly enhanced in osteoblasts cultured on PCL/pearl scaffold compared to PCL control \[[@bib30]\]. These previous works highlighted the benefit of using pearl powders as functional fillers in BTE composite scaffolds. However, they also ignored that calcium carbonate has three different crystal forms including aragonite, vaterite and calcite. Among them, calcite is the most stable polymorph, while vaterite is the most unstable one. Li et al. reported that calcite nanoparticles promoted osteogenesis compared to adipogenesis in human MSCs \[[@bib31]\]. Fricain et al. found that the proliferation and protein expressions of MSCs were comparable on aragonite and calcite, suggesting the similar osteogenic performances of these two CaCO~3~ polymorphs \[[@bib32]\]. So far, the synthesis of pure vaterite phase without using organic template for mineralization still remains as a huge challenge due to the high instability of vaterite under room temperature and atmospheric pressure. Moreover, inorganic calcite easily transforms to aragonite (\>60 °C) or calcite (\<60 °C) once it is exposed to water \[[@bib33]\]. Thus, it is difficult to directly compare the osteogenic capacities between pure aragonite and vaterite. It is speculated that aragonite and vaterite may possess various osteogenic capacities due to their different degradation rates. For pearls, the inorganic component of the lustrous ones is characterized to be aragonite, while that of non-lustrous ones is pure vaterite \[[@bib34]\]. The existing form of calcium carbonate is directly related to the composition of organic component in pearl \[[@bib35]\]. In our previous works, poly-[l]{.smallcaps}-lactic acid (PLLA)/aragonite pearl and PLLA/vaterite pearl scaffolds were successfully prepared by thermally induced phase separation method \[[@bib36],[@bib37]\]. Compared to pure PLLA scaffold, composite scaffolds incorporated with aragonite or vaterite pearl powders exhibited enhanced compressive strength and modulus \[[@bib36]\]. Moreover, the PLLA/aragonite pearl scaffold was found to exhibit stronger stimulatory effect on the proliferation and ALP activity of MSCs compared to PLLA/vaterite pearl scaffold \[[@bib36]\]. It is considered to be related to the different organic matrices and degradation rates of these two kinds of pearl powders. So far, the *in vivo* performances of pearl-containing composite scaffolds still remain to be explored.

Hence, the aim of the current work is to systematically evaluate the biological performances of PLLA/aragonite pearl and PLLA/vaterite pearl composite scaffolds both *in vitro* and *in vivo*. Human osteoblastic SaOS-2 cells and New Zealand white rabbits were employed as cell and animal model, respectively. For comparison, pure PLLA scaffold was also prepared.

2. Experimental procedure {#sec2}
=========================

2.1. Scaffold preparation {#sec2.1}
-------------------------

The scaffolds were prepared by thermally induced phase separation and subsequent freeze-drying as previously reported \[[@bib36]\]. Briefly, PLLA with molecule weight of 17.9 × 10^4^ Da (Shandong Medical Device Company, China) was dissolved in 1, 4-dioxane at a mass-to-volume ratio of 5% (g/mL) by stirring for 8 h at room temperature. Thereafter, aragonite or vaterite pear powders (\~17.5 μm) prepared by mechanical grounding using a grinder were added into the PLLA solution at a mass-to-mass ratio of 20%. After being further stirred for 15 min, the mixture was sonicated for 30 min. Subsequently, the mixture was casted into cylinder-shaped molds (for in *vitro* tests: 15 mm in diameter and 100 mm in length; for *in vivo* tests: 3 mm in diameter and 10 mm in length) and frozen for 24 h at −20 °C. Then, the lyophilization process was carried out for 48 h at −60 °C. The pure PLLA scaffolds were prepared as described above without the addition of pearl powders. The specimens are denoted as PLLA/aragonite or PLLA/vaterite scaffolds depending on the type of added pearl powders.

2.2. Scaffold characterization {#sec2.2}
------------------------------

The specimen microstructure was analyzed by scanning electron microscopy (SEM; FEI Quanta 250FEG, USA). The chemical composition of specimens was evaluated with X-ray photoelectron spectromety (XPS; Thermo Scientific Escalab 250Xi, UK). The binding energy of C 1s (284.8 eV) in CH~2~ group was used to calibrate the spectra.

2.3. Cell culture and seeding {#sec2.3}
-----------------------------

Human osteoblastic SaOS-2 cells were incubated in McCoy\'s medium containing 15% fetal bovine serum (FBS) and 1% antibiotics (100 U/mL penicillin and 100 μg/mL streptomycin) under standard condition (37 °C, 5% CO~2~ and 100% humidity). The culture medium was changed every other day until about 90% confluence was reached.

Before cell seeding, the specimens were cut into discs (15 mm in diameter and 1 mm in thickness) and disinfected using a cobalt-60 source (dose rate: 8 kGy). The sterilized specimens were then placed into 24-well plate and pre-soaked in McCoy\'s complete culture medium for 24 h. Subsequently, 1 mL complete culture medium containing 3 × 10^4^ SaOS-2 cells were dropped onto the surface of each specimen.

2.4. Cell morphology and proliferation {#sec2.4}
--------------------------------------

For SEM observation, the cells were fixed with 2.5% glutaraldehyde solution for 12 h and then dehydrated in ethanol solutions with ascending concentrations (from 20 to 100%, 10 min at each concentration). Subsequently, the intracellular ethanol was substituted using a series of graded tertiary butanol solutions (from 25 to 100% in ethanol, 10 min at each concentration). After freeze drying, the specimens were gold sputtered and analyzed employing SEM.

The proliferation of SaOS-2 cells was determined by Cell Counting Kit-8 (CCK-8, Dojindo, Japan). At each time point, 270 μL of culture medium and 30 μL of CCK-8 solution were added into each well and then incubated for 1 h at 37 °C. Finally, the optical density values of solutions were measured using a microplate analyzer (PerkinElmer, USA) at 450 nm.

2.5. ALP activity and collagen (Col) secretion {#sec2.5}
----------------------------------------------

For qualitative analysis of ALP activity, the specimens were fixed in 4% paraformaldehyde and stained with BCIP/NBT alkaline phosphatase color development kit (Beyotime, China). For ALP activity quantitative assessment, the cells were lysed in 0.2% Triton X-100. The ALP activity in lysates was determined employing an ALP detection kit (Jiancheng, China) and normalized by the total protein content measured by a BCA assay kit (Beyotime, China).

For the measurement of Col synthesis, the cells were fixed and then stained with sirius red (Solarbio, USA) with a concentration of 0.1% at room temperature for 12 h. The stained specimens were washed and photographed. Thereafter, the dyes were dissolved in 0.2 M NaOH/methanol (volume-to-volume ratio = 1:1) for quantitative analysis. The optical density values of solutions were determined by a microplate analyzer at 570 nm.

*2.6*. *In vitro* mineralization {#sec2.6}
--------------------------------

To facilitate mineralization, osteogenic inducers including ascorbic acid (50 μg/mL), dexamethasone (10 nM) and β-glycerophosphate (10 mM) were added into normal culture medium. After culturing SaOS-2 cells in osteogenic medium for 14 days, the specimens were treated as described in section [2.4](#sec2.4){ref-type="sec"} for SEM sample preparation. Thereafter, the deposited minerals were analyzed employing SEM equipped with an energy dispersive X-ray spectroscopy (EDS) system.

2.7. Gene expressions {#sec2.7}
---------------------

The osteogenic gene expressions including osteocalcin (OCN), osteopotin (OPN) and bone sialoprotein (BSP) in SaOS-2 cells cultured on various specimens were analyzed by real time polymerase chain reaction (RT-PCR) assay. After culturing for 3 days, total RNA was extracted using Trizol reagent from cells. The concentration of RNA was measured by a NanoDrop spectrophotometer (Thermo Fisher Scientific, USA). First standard complementary DNA (cDNA) was synthesized from total RNA using Fast-Quant RT kit (Tiangen, China) following manufacturer\'s instructions. The RT-PCR analysis was performed on a CFX96 Touch RT-PCR Detection System (Bio-Rad, USA) using SYBR Green detection reagent (Bio-Rad, USA). The 2-ΔΔCT method was used to analyze data. [Table S1](#appsec1){ref-type="sec"} listed the primers used for SaOS-2 cells in the current work.

2.8. Surgical procedure {#sec2.8}
-----------------------

Bilateral critical-sized segmental radial bone defect model in adult rabbits was employed in the current work. The animal experimentation was approved by the Ethics Committee of the Second Xiangya Hospital of Central South University. In brief, twenty-four male New Zealand white rabbits (6-month-old) with an average weight between 2.5 and 3.0 kg were used. Four experimental groups were specified including blank, PLLA, PLLA/aragonite and PLLA/vaterite. The rabbits were anaesthetized with ear intravenous injection of 3% pentobarbital sodium solution (30 mg/kg). Subsequently, bilateral forelimbs of rabbits were shaved and washed with 70% ethanol. After muscle dissection and radius exposure, a segmental defect of 10 mm was created in the middle of radial bone using a dental bur. The periosteum was removed to reduce the spontaneous regeneration potential of defects. The radius defects were either grafted with as-prepared cylinder scaffolds or left blank. No additional fixation was employed for the forelimbs. Finally, the wounds were closed by suturing. The rabbits were housed separately in cages and each was given penicillin at a dose of 4 × 10^4^ units per day for 5 days post-surgery. The animals were sacrificed successively at week 4, 8 and 12 to obtain their bony tissues.

2.9. X-ray examination {#sec2.9}
----------------------

Immediately after sacrificing the animals, standardized radiographs were performed on the experimental limbs. The images were evaluated according to the Lane-Sandhu radiographic scoring system ([SI Table 2](#appsec1){ref-type="sec"}) to score defect bridging as well as bone formation and modeling \[[@bib38]\].

2.10. Micro-computed tomography (micro-CT) analysis and biomechanical evaluation {#sec2.10}
--------------------------------------------------------------------------------

After X-ray examination, the bony specimens were employed for micro-CT evaluation before mechanical testing or histological analysis. The specimens were scanned using SIEMENS Inveon MMCT micro-CT instrument with voltage and power set as 55 kV and 80 W, respectively. The resolution of imaging was 20 μm in the current work. Using Inveon Acquisition Workplace software, the region of interest (ROI) was chosen as a cylinder area (10 mm in hight) covering the defect created during surgery for quantitative analysis of bone volume/total volume (BV/TV), trabecular number (Tb.Nu), trabecular thickness (Tb·Th) and trabecular separation (Tb.Sp). The biomechanical properties of bony specimens were measured by three-point bending test.

2.11. Histological analysis {#sec2.11}
---------------------------

The bony specimens were fixed with 10% formaldehyde solution and decalcified in 12.5% EDTA. After complete decalcification and dehydration, the specimens were embedded in paraffin and cut into 5 mm serial sections. The sections were stained with hematoxylin/eosin (H&E) or Masson\'s trichrome method and subsequently photographed using optical microscopy. It is worthy of mentioning that light green (0.5 g light green in 100 mL distilled water) was employed for collagen fiber staining in the process of Masson\'s trichrome staining.

2.12. Statistical analysis {#sec2.12}
--------------------------

Results were shown as mean ± standard deviation (SD). All data were generated from three or four independent experiments. Statistical analysis was conducted employing one-way analysis of variance (ANOVA) followed by post hoc tests. A value of p \< 0.05 was considered to be significant.

3. Results and discussions {#sec3}
==========================

3.1. Characterizations of scaffolds {#sec3.1}
-----------------------------------

As shown in [Fig. 1](#fig1){ref-type="fig"}, all PLLA-based scaffolds exhibited a similar macro-porous microstructure. At a low magnification (500 × ), it was found that interconnected pores with sizes ranging from 50 to 150 μm were homogeneously distributed in scaffold matrices. The pores exhibited a ladder-like morphology due to the directional crystallization of solvent during freezing. At a high magnification (2500 × ), morphological differences were noticed between various groups. For PLLA group, the scaffold surface was relatively smooth. However, the surfaces of composite scaffolds were found to be rougher owing to the presence of evenly distributed pearl powders (indicated by the white arrows). Scaffolds with pore sizes ranging from 20 to 1500 μm were previously reported to be used for BTE applications \[[@bib39], [@bib40], [@bib41]\]. Commonly, small pores (100--150 μm) are considered to be critical for nutrition transport and cell infiltration \[[@bib42]\]. Larger pores (\>300 μm) were found to be required for substantial bone in-growth \[[@bib41]\]. Thus, the initial pores of scaffolds in the current work were not large enough for long-term bone in-growth. The degradation of scaffolds after implantation is considered to be essential for the formation of larger pores that support bone regeneration.Fig. 1(a) The SEM images of various scaffolds and (b) their relevant XPS spectra. The white arrows showed the presence of pearl powders within composite scaffolds.Fig. 1

The chemical compositions of specimens were explored by XPS technique. Consistent with the composition of PLLA, only C and O signals were detected for PLLA scaffold ([Fig. 1](#fig1){ref-type="fig"}b). For composite scaffolds, additional elements including Ca and N were detected. The element Ca was attributed to the presence of inorganic component CaCO~3~ and N was corresponding to the peptide --NH~2~ group within pearl \[[@bib43]\]. According to our previous work, the content of WSM in aragonite pearl (\~1.02 wt%) was higher than that in vaterite pearl (\~0.79 wt%). However, aragonite pearl contained less acid soluble matrix (ASM) and acid insoluble matrix (AIM) than vaterite pearl \[[@bib35]\]. As differences in the organic components of aragonite and vaterite pearls are speculated to lead to various osteogenesis, the biological performances of composite scaffolds were assessed both *in vitro* and *in vivo*.

*3.2*. *In vitro* biological performance {#sec3.2}
----------------------------------------

### 3.2.1. Osteobalst morphology and proliferation {#sec3.2.1}

The morphology and proliferation of SaOS-2 cells on various scaffolds were investigated by SEM visualization and CCK-8 test, respectively. As shown in [Fig. 2](#fig2){ref-type="fig"}a, the cells exhibited a roundish morphology following the initial attachment onto scaffolds for 1 day. The cells were more flattened on composite scaffold surfaces compared to those on PLLA scaffold. On day 3, further spreading and cytoskeleton extension were noticed for cells attached on all scaffold surfaces. The cells continued to proliferate and more cells were observed on day 5. On PLLA/aragonite scaffold surface, the cells reached almost confluence and cell borders became indistinguishable. Consistent with SEM observation, the CCK-8 results showed that PLLA/aragonite scaffold stimulated the proliferation of SaOS-2 cells compared to the other two groups ([Fig. 2](#fig2){ref-type="fig"}b). Compared to PLLA scaffold, PLLA/vaterite scaffold support the growth of cells without showing significant stimulatory effect.Fig. 2(a) The SEM images of SaOS-2 cells grown on various scaffolds for 1, 3 and 5 days as well as (b) relevant cell proliferation behaviors evaluated by CCK-8 assay. \*p \< 0.05 and \*\*p \< 0.01.Fig. 2

### 3.2.2. Osteoblast differentiation {#sec3.2.2}

The differentiation of SaOS-2 cells grown on various scaffolds for different durations was evaluated. As shown in [Fig. 3](#fig3){ref-type="fig"}a, PLLA/aragonite scaffold promoted the ALP activity of SaOS-2 cells compared to the other two groups on both day 4 and 7. The Col productions in SaOS-2 cells on day 5 and 10 were in the following order: PLLA/aragonite \> PLLA/vaterite \> PLLA ([Fig. 3](#fig3){ref-type="fig"}b). After culturing SaOS-2 cells on PLLA/aragonite scaffold for 14 days with the supplement of mineralization inducers, the formation of bone-like nodules was observed on the surface of PLLA/aragonite scaffold ([Fig. 3](#fig3){ref-type="fig"}c, indicated by the white arrows). The nodules were consisted of nano-crystals with an average size of 20 nm. As shown in [Fig. 3](#fig3){ref-type="fig"}d, elemental signals of C, Ca, O, P and Na were detected for the nodules, indicating that the nodules were Ca- and P-containing minerals. However, the formation of bone-like nodules was rarely found on PLLA or PLLA/vaterite scaffold (SI [Fig. 1](#fig1){ref-type="fig"}). The osteogenic gene expressions were evaluated by RT-PCR technique. As shown in [Fig. 3](#fig3){ref-type="fig"}e, composite scaffolds up-regulated the gene expressions of OCN, OPN and BSP compared to PLLA scaffold in general, although the BSP gene expressions were comparable between PLLA and PLLA/vaterite group. Compared to those in PLLA/vaterite group, the levels of OCN and OPN expressions were significantly higher in PLLA/aragonite group. Together, the results suggest that incorporating pearl powders (aragonite or vaterite) into PLLA scaffold could lead to enhanced differentiation of SaOS-2 cells *in vitro*. The stimulatory effect was found to be stronger in PLLA/aragonite group compared to PLLA/vaterite group. In our previous work, the ALP activity of MSCs was promoted by PLLA/aragonite scaffold, while slightly inhibited by PLLA/vaterite scaffold \[[@bib36]\]. This inconsistency is considered to be caused by the usage of different cellular types.Fig. 3(a) The ALP activity, (b) Col synthesis of SaOS-2 cells cultured on various surfaces for different durations. (c) *In vitro* mineralization of SaOS-2 cells grown on PLLA/aragonite scaffold for 14 days and (d) EDS elemental analysis of the mineral deposits (point A). The gene expressions of osteogenic markers including OCN, OPN and BSP evaluated by RT-PCR technique on day 3. \*p \< 0.05 and \*\*p \< 0.01.Fig. 3

*3.3*. *In vivo* biological performance {#sec3.3}
---------------------------------------

Critical-sized bone defects are of great importance for the evaluation of osteogenic potential of BTE scaffolds. Hollinger et al. suggested that the defect of long cannular bone could not heal spontaneously when defect size-to-bone diameter ratio was larger than 1.5 \[[@bib44]\]. Commonly, the radius diameter of rabbits is in the range of 3--4 mm. According to previous literatures, radius defects with sizes ranging from 10 to 20 mm were described as being of critical size for rabbits \[[@bib45],[@bib46]\]. Zhou et al. reported that the rabbit radius defect with a size of 10 mm could maintain its size throughout a 12-week period after the removal of periosteum \[[@bib47]\]. To investigate the *in vivo* bone regeneration capacity of PLLA/pearl powders composite scaffolds, a rabbit critical-sized segmental radial bone defect model was employed in the current work ([Fig. 4](#fig4){ref-type="fig"}a).Fig. 4(a) The surgical procedure and macroscopic morphology of scaffolds. (b) The digital radiographs and (c) Lane-Sandhu radiographic scores of rabbit radius defects implant with various scaffolds at week 4, 8 and 12 post-surgery. \*p \< 0.05 and \*\*p \< 0.01.Fig. 4

### 3.3.1. Radiography {#sec3.3.1}

As shown in [Fig. 4](#fig4){ref-type="fig"}b, the formation of new bone was non-obvious in all groups at week 4. Tiny bone callus formed at the end of bone defect was noticed in PLLA group at week 8, while distinct formation of bone callus was found in the osteotomy gaps implanted with composite scaffolds. At week 12, the defect of PLLA group was filled with newly formed bone callus without reaching bridging, while the defects in the composite scaffold groups were bridged with new bone. The radiograph density of defect in PLLA/aragonite group was found to be larger than that in PLLA/vaterite group. The osteotomy gap was still obviously visible in the blank control group at week 12 ([Fig. 4](#fig4){ref-type="fig"}b). As shown in [Fig. 4](#fig4){ref-type="fig"}c, the Lane-Sandhu scoring system was employed to evaluate the conditions of bone bridging and formation in defects implanted with scaffolds. At week 4, the scores were comparable for all groups. With prolonged durations (week 8 and 12), the scores of various groups were basically in the following trend: PLLA/aragonite \> PLLA/vaterite \> PLLA, although there was no statistically significant difference between the scores in PLLA/aragonite and PLLA/vaterite groups at week 8.

### 3.3.2. Micro-CT evaluation {#sec3.3.2}

Compared to the scoring of radiographs, 3D reconstructed micro-CT images allowed for a more precise assessment of new bone formation within the osteotomy gaps. As shown in [Fig. 5](#fig5){ref-type="fig"}a, more newly formed trabecular bone tissues were observed in defects of composite scaffold groups compared to PLLA group at week 8. Till week 12, obvious bone bridging was noticed in both groups implanted with composite scaffolds, indicating the true osteoconductive nature of composite scaffolds. Compared to PLLA/vaterite group, a relatively more intact radius contour was formed in PLLA/aragonite group. However, the bridging of defect in PLLA group was atypical at week 12, which could be regarded as non-bridging. As shown in [Fig. 5](#fig5){ref-type="fig"}b--e, quantitative histograms of bone formation were obtained. At week 8, the bone regeneration performance of various groups basically followed the trend: PLLA/aragonite \> PLLA/vaterite \> PLLA. At week 12, the values of BV/TV and Tb.Nu were comparable for composites scaffolds and higher than those of PLLA scaffold ([Fig. 5](#fig5){ref-type="fig"}b and d). The PLLA/aragonite group still possessed smaller Tb.Sp value compared to PLLA/vaterite group at week 12 ([Fig. 5](#fig5){ref-type="fig"}e). However, the Tb·Th values reached the same level for all groups without showing statistically significant difference ([Fig. 5](#fig5){ref-type="fig"}c). In general, the micro-CT results revealed that composite scaffolds exhibited better bone healing performances compared to pure PLLA scaffold.Fig. 5(a) The micro-CT analysis of different groups at week 8 and 12 as well as quantitative parameters of defect healing process obtained from micro-CT images: (b) BV/TV; (c) Tb·Th; (d) Tb.Nu and (e) Tb·Sp. \*p \< 0.05 and \*\*p \< 0.01.Fig. 5

### 3.3.3. Histological analysis {#sec3.3.3}

To further evaluate the healing process of bone defects in various groups. H&E (SI [Fig. 2](#fig2){ref-type="fig"}) and Masson\'s trichrome ([Fig. 6](#fig6){ref-type="fig"}) staining were performed at week 4, 8 and 12 post-surgery. As shown in [Fig. 6](#fig6){ref-type="fig"}, a typical endochondral bone formation process was revealed by Masson\'s trichrome staining. The theory of endochondral bone formation could be divided into three stages including inflammation and cartilage formation (initial stage), primary bone formation (secondary stage) and bone remodeling (maturation stage) \[[@bib17]\]. For the initial stage, the inflammatory cells presented at bone defect site release various kinds of cytokines to raise an acute inflammatory response and simultaneously recruit MSCs towards the defect site. The recruited MSCs subsequently differentiate into chondrocytes and form cartilage. For the secondary stage, the cartilage transforms to woven bone through the osteogenic activity of osteoblasts. Finally, the woven bone undergoes remodeling and gradually turns into matured lamellar bone. In the current work, the pores of scaffolds were infiltrated with abundant chondrocytes at week 4. The formation of woven bone was observed in all groups at week 8. Compared to the other two groups, PLLA/aragonite scaffold resulted in enhanced woven bone formation. Till week 12, the woven bone transformed to lamellar bone in PLLA/aragonite and PLLA/vaterite group. Typical Haversian osteons with a ring-like structure were observed within the lamellar bone tissue. The maturity of lamellar bone in PLLA/aragonite group was significantly higher than that in PLLA/vaterite group. However, the formation of lamellar bone was not observed in PLLA group. Similarly, Lamghari et al. reported that nacre powders induced spinal fusion of rabbits *in vivo* by endochondral bone formation \[[@bib22]\]. The degradation of scaffolds was noticed in all groups although complete degradation was not achieved till week 12. Consistently, Walton reported that the presence of PLLA *in vivo* even after implantation for 3 years \[[@bib48]\]. Thus, PLGA is more recommended to be used as scaffold material compared to PLLA as its degradation rate can be largely controlled by adjusting the ratio between PLA and PGA \[[@bib49]\]. It is well-known that PLLA degrades by hydrolytic cleavage of its polymer chains \[[@bib50]\]. The acidic micro-environment created by proton release may lead to emergence of chronic inflammation \[[@bib51]\]. However, no obvious inflammation was noticed in the current work, indicating that the effect of acidity could be neglected for highly porous PLLA scaffold. For composite scaffolds, the degradation of pearl powders could raise the environmental pH to some extent and neutralize the protons released by PLLA \[[@bib37]\].Fig. 6The histological micrographs of Masson\'s trichrome staining of bone defects in each group at week 4, 8 and 12 post-surgery. RM, CC, WB, LB and HO were denoted for residual materials, chondrocytes, woven bone, lamellar bone and Haversian osteons, respectively.Fig. 6

### 3.3.4. Biomechanical evaluation {#sec3.3.4}

For rabbit limbs, a load is commonly shared by the syndesmosis between radius and ulna. Guda et al. suggested that the radius and ulna should be considered as a unit in the physiological setting \[[@bib52]\]. It is considered to be more biologically-relevant to conduct the biomechanical test on them together. Thus, the radius was not separated from the ulna for three-point bending test in the current work ([Fig. 7](#fig7){ref-type="fig"}a). As shown in [Fig. 7](#fig7){ref-type="fig"}b, the values of maximum bending load were comparable for various groups at week 4. The PLLA/aragonite group could bear significantly larger bending load compared to other two groups at week 8 and 12. No significant difference was found between the PLLA and PLLA/vaterite group throughout a 12-week period of time.Fig. 7(a) The experimental procedure of three-point bending test performed on rabbit forelimbs and (b) maximum bending load of the regenerated forelimbs at week 4, 8 and 12. \*p \< 0.05 and \*\*p \< 0.01.Fig. 7

In this study, aragonite or vaterite pearl powders were added into PLLA scaffold as functional fillers. The biological performances of as-fabricated composite scaffolds were systematically evaluated both *in vitro* and *in vivo*. According to the results presented in this work, the composite scaffolds were found to exhibit enhanced osteogenic capacity compared to pure PLLA scaffold. Moreover, PLLA/aragonite scaffold possessed stronger stimulatory effect on bone regeneration compared to PLLA/vaterite scaffold. The underlying mechanism of the stimulatory effect of PLLA/aragonite scaffold on bone healing is still an open question, to which some ideas might be provided here by combining current theories with our findings. As pearl is a composite material composed of inorganic CaCO~3~ and organic matrix, it is reasonable to speculate that at least one of these components is responsible for the enhanced osteogenesis. For the inorganic component of pearl, it is well-known that the dissolution and hydrolysis of CaCO~3~ in an aqueous environment can lead to the release of Ca^2+^ and increase of environmental pH. In previous work, we measured the alkalinity of various scaffold-soaked culture media (soaking for 1 day) and found that the pH values were in the order: PLLA/vaterite (pH \~7.4) \> PLLA/aragonite (pH \~7.3) \> PLLA (pH \~7.2) \[[@bib36]\]. Moreover, the Ca^2+^ concentrations released from PLLA/aragonite and PLLA/vaterite scaffold which were immersed in phosphate buffer solution (PBS) for 7 days were measured to be \~0.26 and \~0.31 mM, respectively \[[@bib37]\]. These results are consistent with previous finding that vaterite has a higher solubility and degradation rate than aragonite \[[@bib33]\]. Previous literatures suggested that an alkaline microenvironment (pH 7.8--8.5) could promote osteogenesis by stimulating the activity of osteoblasts \[[@bib53], [@bib54], [@bib55]\]. Meanwhile, Maeno et al. reported that 2--4 mM Ca^2+^ was suitable for the survival and proliferation of osteoblasts, while 6--8 mM Ca^2+^ was beneficial for osteoblast maturation and matrix mineralization \[[@bib56]\]. Obviously, the environmental pH and Ca^2+^ concentration in PLLA/agragonite- or PLLA/vaterite-soaked medium are both within the tolerant ranges for osteoblasts. Thus, the dissolution of CaCO~3~ could be partially responsible for the enhanced osteogenesis of composite scaffolds compared to pure PLLA. However, the high dissolution rate of vaterite did not lead to enhanced osteogenesis in PLLA/vaterite group compared to that in PLLA/aragonite group. Therefore, the dissolution of CaCO~3~ does not explain the superior bone regeneration potential of PLLA/aragonite scaffold over PLLA/vaterite scaffold. This indicates that the organic matrix of aragonite pearl is likely to be more responsible for the enhanced osteogenic capacity of PLLA/aragonite scaffold compared to that of PLLA/vaterite scaffold. According to previous literatures, it is suggested that the osteogenic molecules may be contained in the WSM of nacre and pearl \[[@bib23],[@bib26]\]. Aragonite pearl was found to possess higher content of WSM compared to vaterite pearl \[[@bib35]\]. Thus, it is speculated that the WSM in aragonite pearl may contain more osteogenic molecules or factors which are more biologically active than that in vaterite pearl. In the future, further attention should be paid on the molecular composition of WSM in pearl in order to unveil the exact mechanism of the excellent osteogenic potential of aragonite pearl. Considering the high cost and short half-lives of growth factors such as BMP-2 and VEGF, aragonite pearl powders which contain natural osteogenic molecules within their organic matrix could be employed as functional fillers in composite scaffolds for BTE applications.

4. Conclusions {#sec4}
==============

In summary, the biological performances of PLLA/aragonite and PLLA/vaterite scaffold were systematically evaluated both *in vitro* and *in vivo*. The results showed that incorporating pearl powders into PLLA scaffold enhanced *in vitro* osteogenesis and *in vivo* bone regeneration. The crystal form of pearls is critical for the biological performances of composite scaffolds. PLLA/aragonite scaffold exhibited superior osteogenic capacity over PLLA/vaterite scaffold, evidenced by the promoted cell proliferation and differentiation *in vitro* as well as the enhanced bone healing efficacy *in vivo*. Together, PLLA/aragonite scaffold is considered as a potential bone substitute material for BTE applications.
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